Profile Evaluation: WE:4 years, Indian, Healthcare Bgnd
[#permalink]
26 Oct 2010, 07:56
Hi,
I'm an MBA Aspirant with the following profile:
Age:27
730 GMAT (Q50, V39) AWA 5.5
GPA : UG (3.2) My weakness
PG: 3.4 GPA ( MS Biomedical Engineering, USC)
Work Ex:
1 year in a Hospital in India
3 Years in Regulatory Affairs (with a Leadership Rotation in Clinical Affairs) in a Fortune 500 Company( Medical Device) - Decent job growth
Notable Accomplishments: Work on Clinical Trials. Solely, conceived, refined and implemented a Clinical Strategy (change to the Biostats plan) that allowed Product launch in market 4 months ahead of time. Won Company wide Award for this. Net impact in the Millions.
Led the formation of a special group (with team charter, roles and responsibilities etc) . Led Clinical Trial for next-generation medical device. All this in addition to job in Regulatory Affairs (which was being involved in Core Teams from day 1, leading product from bench to bedside).
Quite a lot of Customer Interaction (FDA and Key Opinion Leaders in Vascular Surgery)
Extra currics:
Editor of College Magazine
on the cusp of starting an online community based venture
Led American Heart Association Fundraiser. Exceeded previous year's goal by 120%
Heavily involved in the Company's Employee resource groups
Heavily involved with the volunteerism council at Work
Represented College in table tennis
Reason for MBA: Complement existing regulatory/clinical/reimbursement experience with financial and economic acumen to further development within the healthcare industry.
Reason for MBA: Complement existing regulatory/clinical/reimbursement experience with financial and economic acumen to further development within the healthcare industry. I want to move into Corporate Development/Business Development. That's why i'm looking at some specialty finance schools as well.
My question is that I'm applying to some really good programs and am worried about being too ambitious.
My School picks are :
Harvard
Wharton (for Healthcare management)
Stern (for Finance)
MIT
Columbia
Please advise